Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pannuti

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Minerva Medica|September 1, 1980
[Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses]A Martoni, G Pedelini, G Colalongo, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1990
Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposideM Casadio, G Lelli, S Giordani, et al.
Pharmacological Research Communications|June 1, 1983
The anabolic effect of high dose medroxyprogesterone acetate in oncologyG Lelli, B Angelelli, M E Giambiasi, et al.
Tumori|July 25, 1998
Hospital-at-Home for advanced cancer patients within the framework of the Bologna Eubiosia project: an evaluationS Tanneberger, F Pannuti, R Mirri, et al.
Anticancer Research|November 1, 1993
Aminoglutethimide in advanced breast cancer: prospective, randomized comparison of two dose levels. Italian Cooperative GroupG Robustelli della Cuna, F Pannuti, A Martoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover studyC M Camaggi, E Strocchi, P Carisi, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Epirubicin pharmacokinetics after intrahepatic arterial and intraperitoneal administrationE Strocchi, C M Camaggi, A P Rossi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumorsA Martoni, M Giovannini, L Tomasi, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1992
Chemotherapy with cisplatin, epirubicin, methotrexate in the treatment of locally advanced or metastatic transitional cell cancer of the bladder (TCC)G Lelli, B Melotti, F Pannuti, et al.
Cancer Investigation|January 1, 1991
Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinomaP Periti, F Pannuti, G R Della Cuna, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Minerva Medica|September 1, 1980
[Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses]A Martoni, G Pedelini, G Colalongo, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1990
Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposideM Casadio, G Lelli, S Giordani, et al.
Pharmacological Research Communications|June 1, 1983
The anabolic effect of high dose medroxyprogesterone acetate in oncologyG Lelli, B Angelelli, M E Giambiasi, et al.
Tumori|July 25, 1998
Hospital-at-Home for advanced cancer patients within the framework of the Bologna Eubiosia project: an evaluationS Tanneberger, F Pannuti, R Mirri, et al.
Anticancer Research|November 1, 1993
Aminoglutethimide in advanced breast cancer: prospective, randomized comparison of two dose levels. Italian Cooperative GroupG Robustelli della Cuna, F Pannuti, A Martoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover studyC M Camaggi, E Strocchi, P Carisi, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Epirubicin pharmacokinetics after intrahepatic arterial and intraperitoneal administrationE Strocchi, C M Camaggi, A P Rossi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumorsA Martoni, M Giovannini, L Tomasi, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1992
Chemotherapy with cisplatin, epirubicin, methotrexate in the treatment of locally advanced or metastatic transitional cell cancer of the bladder (TCC)G Lelli, B Melotti, F Pannuti, et al.
Cancer Investigation|January 1, 1991
Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinomaP Periti, F Pannuti, G R Della Cuna, et al.
Pageof 10